A study to evaluate the effect of kidney disease, from mild to severe disease, on a diabetes medication
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
24
Determination of the pharmacokinetics of MK0431 (sitagliptin phosphate) in patients with renal insufficiency compared to healthy volunteers
Safety and tolerability in patients with renal insufficiency
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.